In the News – Temple University Risk Communication Laboratory

All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011-2006

Prevalence and Predictors of Medical Mistrust Among Socioeconomically and Racially Diverse Cancer Patients in Philadelphia

Temple researchers examined medical mistrust in diverse cancer patients using two scales. The study highlights the prevalence of institutional and race-based mistrust and their impact on healthcare trust.

February 14, 2025

Making Public Health Personal: Dr. Sarah Bass's Commitment to Community Health in North Philadelphia

Temple’s Risk Communication Lab, led by Dr. Sarah Bass, boosts vaccine uptake through community-driven outreach. Recent efforts doubled booster rates in North Philadelphia, highlighting the power of local engagement in public health.

January 23, 2025

Qualitative Assessment of a Novel Intervention to Reduce Hospital Readmission Risk Among People with Diabetes

Temple researchers evaluated the Diabetes Transition of Hospital Care (DiaTOHC) program, a novel intervention aimed at reducing 30-day hospital readmissions for people with diabetes.

December 30, 2024

The Power of Perception: Temple Research Looks at how College Students View Vaccine Mandates

Three studies from faculty at Temple’s College of Public Health use data from students at four Pennsylvania universities to examine the relationship between perceptions of vaccine mandates and vaccine uptake.

December 17, 2024

Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community

Fox Chase Cancer Center (FCCC) published an article that highlights the work that the Risk Communication Lab and our collaborators at FCCC are doing that brings Fox Chase’s innovative care to the Temple community.

February 27, 2024

Decision-Support Application for Cancer Patients Gets Further Funding

The Risk Communication Laboratory received further funding from the National Cancer Institute (NCI) to expand the Gene Pilot tool, which helps educate cancer patients about a test called tumor genomic profiling and articulate common concerns patients have about the procedure.

October 26, 2023